Osteogenesis imperfecta type 18 is a rare genetic form of brittle bone disease that is usually recognized before birth or in early infancy. People with osteogenesis imperfecta type 18 often have very fragile bones, repeated fractures, poor growth, and bone shape changes, and early signs of osteogenesis imperfecta type 18 may also include breathing problems in severe cases. It is a lifelong condition, and the severity can vary. Not everyone will have the same experience. Treatment for osteogenesis imperfecta type 18 focuses on supportive care such as fracture management, physical therapy, breathing support when needed, and sometimes medicines to strengthen bone, but severe cases can be life-threatening, especially around birth or early infancy.
How many people live with Osteogenesis imperfecta type 18?
Worldwide and U.S. estimates for osteogenesis imperfecta type 18, a very rare form of brittle bone disease, have not been reliably published by a single authoritative source. For context, osteogenesis imperfecta overall is estimated to affect about 500,000 people worldwide and about 25,000 to 50,000 people in the United States (Osteogenesis Imperfecta Foundation, 2024), but type 18 is one of the rarest forms, so no dependable subtype-specific global or U.S. count is available.
Overview
Osteogenesis imperfecta type 18Symptoms
Osteogenesis imperfecta type 18 mainly causes very fragile bones, so breaks can happen before or soon after birth. Many babies also have short arms and legs. Growth may be poor, and the chest can be small.
Outlook and prognosis
Osteogenesis imperfecta type 18 is usually a severe form, with frequent fractures, short stature, and bone changes that can limit walking and daily activities. Outlook varies, but many living with osteogenesis imperfecta type 18 need lifelong orthopedic, breathing, and rehabilitation support.
Causes and risk factors
Osteogenesis imperfecta type 18 is caused by harmful changes in the MBTPS2 gene, usually inherited in an X-linked pattern, though new changes can happen. Family history raises the chance, while severity can vary with overall health, nutrition, and fracture-related complications.
Genetic influences
Genetics are central to osteogenesis imperfecta type 18. It is caused by harmful changes in the PLS3 gene, and different genetic variations can affect how severe symptoms are, even within the same family.
Diagnosis
Diagnosis of osteogenesis imperfecta type 18 usually starts with clinical features such as frequent fractures, bone changes, and growth concerns. Doctors often confirm it with genetic tests, and imaging findings like X-rays can help support the diagnosis.
Treatment and drugs
Osteogenesis imperfecta type 18 treatment focuses on fragile bones and breathing or feeding problems seen early in life. Care may include gentle handling, splints or surgery for fractures, physical therapy, and medicines such as bisphosphonates. Specialist follow-up is important.
Symptoms
Daily life with Osteogenesis imperfecta type 18 often involves protecting fragile bones, adapting movement, and keeping a close eye on growth and breathing. For many people with Osteogenesis imperfecta type 18, features appear very early and can include repeated fractures, bowed arms or legs, and delays in motor skills. Features vary from person to person, but the condition often affects bone shape, strength, and physical development.
Bones can break with very little force, sometimes during routine handling or ordinary play. In Osteogenesis imperfecta type 18, fractures may begin before birth or in infancy and can happen more than once over time. Repeated breaks can make movement more limited and painful.
The arms or legs may look curved or bent because fragile bones change shape as they grow. This can affect balance, standing, and how easily someone can move from place to place.
Growth is often slower than usual, so babies and children may be much shorter than expected for age. Smaller body size can affect everyday tasks such as transfers, positioning, and choosing supportive equipment.
Low muscle tone and bone fragility can make it harder to lift the head, sit, crawl, stand, or walk on the usual timeline. Some children need physical therapy, adaptive seating, or mobility aids to move more safely.
How people usually first notice Osteogenesis imperfecta type 18?
How osteogenesis imperfecta type 18 is first noticed often depends on how severe it is, but many families first learn something is wrong during pregnancy when an ultrasound shows bones that look unusually short, bowed, or fragile, sometimes with fractures before birth. In other babies, the first signs of osteogenesis imperfecta type 18 appear at birth or in early infancy, when doctors notice repeated fractures, soft or poorly mineralized bones, a small chest, or trouble with growth and movement. Because this is a rare genetic form of brittle bone disease, the exact pattern can vary, but early bone fragility is usually what brings it to medical attention.
Types of Osteogenesis imperfecta type 18
No distinct types of Osteogenesis imperfecta type 18 are widely recognized.
Can I slow down the onset of symptoms?
No, there is no good evidence that lifestyle changes or medicines can meaningfully delay when symptoms start in osteogenesis imperfecta type 18, because it is an inherited brittle bone condition that usually begins before birth or in early infancy. Early care from doctors who know this condition well can help lower the chance of some problems and support growth, movement, and comfort, but it does not prevent the condition or reliably push back its start. While research is still ongoing, the most helpful step right now is early, steady care to give a child the best support possible.
What genetics can tell you about symptoms
Yes. In osteogenesis imperfecta type 18, the genetic change is closely linked to a very severe form of brittle bone disease, so genetic testing can help explain why many living with this type have frequent fractures, very soft or bent bones, poor growth, and symptoms that often start before birth or in the newborn period. Genetics can give useful clues about how severe the condition may be and when it may begin, but symptoms can still vary from one person to another.
Causes and risk factors
Frequent fractures can begin early in osteogenesis imperfecta type 18 because bones do not gain normal strength. The underlying cause is a harmful change in the KDELR2 gene, which is usually inherited from both parents and disrupts collagen, a protein that helps strengthen bone. Family history is the main risk factor, and genetic testing can sometimes clarify your personal risk. Low vitamin D, limited movement, and repeated falls do not cause osteogenesis imperfecta type 18, but they can make fractures more likely. Good nutrition, safe activity, and prompt fracture care cannot prevent the condition, but they can affect how severely it impacts daily life.
What are the most common causes or risk factors?
Osteogenesis imperfecta type 18 is caused by inheriting two nonworking copies of a gene called KDELR2, which helps the body process collagen, an important material that gives bones strength. The main risk factors are having both parents carry the same rare gene change, having a family history of the condition, and having parents who are blood relatives, which makes sharing the same gene change more likely. There are no known lifestyle or pregnancy-related causes.
Environmental and biological risk factors
For osteogenesis imperfecta type 18, doctors have not identified clear environmental or other body-based factors that are known to make the condition occur. Researchers are still exploring how outside influences interact with our inner biology. In practice, this means pregnancy exposures, parental age, and similar factors have not been confirmed as causes of this specific type.
Radiation, heavy metals, air pollution, and hormone-disrupting chemicals can affect fetal development in general. However, they are not established risk factors for osteogenesis imperfecta type 18 based on current evidence.
Advanced maternal or paternal age can raise the chance of some congenital conditions. That link has not been clearly shown for osteogenesis imperfecta type 18.
Some maternal illnesses or severe nutrient deficiencies can influence bone growth before birth. They have not been confirmed as causes of osteogenesis imperfecta type 18.
Prematurity or birth trauma can make a newborn seem more fragile or lead to fractures around delivery. They are not known to increase the likelihood of osteogenesis imperfecta type 18 itself.
Genetic risk factors
When a baby or child has unusually fragile bones and repeated fractures, families often ask about the genetic causes of Osteogenesis imperfecta type 18. In most cases, Osteogenesis imperfecta type 18 happens because both copies of a gene called TENT5A are not working properly. Some risk factors are inherited through our genes. The main genetic risks are having carrier parents, a family history of the condition, or parents who are biologically related.
TENT5A changes: Osteogenesis imperfecta type 18 is caused by disease-causing changes in both copies of the TENT5A gene. TENT5A helps bone-forming cells build and maintain strong bone tissue, so changes in both copies can lead to very fragile bones.
Recessive inheritance: Osteogenesis imperfecta type 18 usually follows an autosomal recessive inheritance pattern. This means a child is affected only if one altered TENT5A copy is inherited from each biological parent.
Carrier parents: Parents who carry one altered TENT5A copy are often healthy and may not know they are carriers. If both biological parents are carriers, each pregnancy has a 25% chance of Osteogenesis imperfecta type 18.
Family history: Having a brother, sister, or close relative with confirmed Osteogenesis imperfecta type 18 raises the chance that the same gene change runs in the family. Even if relatives were never formally diagnosed, a pattern of very fragile bones or repeated fractures can be an important clue.
Related parents: When biological parents are related by blood, they are more likely to carry the same rare TENT5A variant. That makes autosomal recessive conditions like Osteogenesis imperfecta type 18 more likely.
Lifestyle risk factors
Osteogenesis imperfecta type 18 is an inherited bone-fragility disorder, so lifestyle habits do not cause it. However, how lifestyle affects osteogenesis imperfecta type 18 can be important for fracture risk, mobility, pain, and day-to-day function. The main lifestyle risk factors for osteogenesis imperfecta type 18 are the ones that increase falls, weaken bone support, or make complications harder to manage.
High-impact sports, jumping, rough contact, or poorly adapted exercise can raise the chance of fractures in fragile bones. Safer, supervised low-impact movement can help maintain strength and joint function without the same level of skeletal stress.
Too little movement can worsen muscle weakness, reduce balance, and increase deconditioning, which may make falls and loss of mobility more likely. Regular tailored physiotherapy and gentle weight-bearing activity may improve stability and support around vulnerable bones.
Low intake of calcium, vitamin D, protein, or total calories can make it harder to support bone mineralization, muscle strength, and recovery after fractures. In children especially, undernutrition may further limit growth and physical resilience.
Very limited sunlight exposure can contribute to low vitamin D levels, which may worsen poor bone health in someone who already has severe skeletal fragility. Monitoring vitamin D status and correcting deficiency can be an important part of care.
Risk prevention
Osteogenesis imperfecta type 18 is a genetic condition, so there is no proven way to prevent the condition itself once a person has it. Prevention usually means lowering the risk of fractures, breathing problems, poor growth, and other complications so daily life is safer and more comfortable. Different people need different prevention strategies—there’s no single formula.
If osteogenesis imperfecta type 18 runs in your family or a child has already been diagnosed, genetic counseling can help clarify recurrence risk in future pregnancies. Testing may help some families understand reproductive options, including prenatal testing or assisted reproduction in selected cases.
Regular care with clinicians experienced in brittle bone disorders can catch problems early, including spine changes, growth concerns, and repeat fractures. Ongoing review is one of the main ways to reduce fracture risk in osteogenesis imperfecta type 18.
Careful lifting, dressing, diapering, transfers, and positioning can help prevent accidental fractures, especially in babies and young children. Families are often taught gentler ways to support the trunk and limbs without twisting or pulling.
Guided movement and physical therapy can build strength, protect joints, and improve balance without putting too much force on fragile bones. For many living with osteogenesis imperfecta type 18, this can mean safer sitting, standing, or walking over time.
Can you prevent Osteogenesis imperfecta type 18?
No, osteogenesis imperfecta type 18 usually cannot be prevented, because it is caused by a gene change that is present from the start of pregnancy. If this condition runs in your family, genetic counseling and family testing may help you understand the chance of having an affected child and discuss reproductive options, but they cannot guarantee prevention.
Transmission
Osteogenesis imperfecta type 18 is not infectious, so it cannot be caught from another person through close contact, the air, food, or blood. For families, the key question is how osteogenesis imperfecta type 18 is inherited: it is usually passed down in an autosomal recessive pattern, meaning a child must inherit one changed copy of the gene from each parent.
Parents who carry one changed copy are often healthy themselves and may not know they are carriers until a child is diagnosed. When both parents are carriers, each pregnancy has a 25% chance of osteogenesis imperfecta type 18, a 50% chance of having a child who is also a carrier, and a 25% chance of having a child who does not have the condition and is not a carrier.
When to test your genes
Consider genetic testing for osteogenesis imperfecta type 18 if prenatal ultrasound shows fractures, bowed limbs, or poor bone mineralization, or if a baby has unexplained fractures, severe bone fragility, or a family history of OI. Early testing can confirm the diagnosis, guide fracture and breathing care, and clarify recurrence risk for future pregnancies.
Diagnosis
Many living with osteogenesis imperfecta type 18 come to medical attention because of frequent fractures, low bone strength, or growth and skeletal changes noticed early in life. Diagnosis is usually based on these clinical features and then confirmed with targeted testing. Getting a diagnosis is often a turning point toward answers and support.
Doctors look at the pattern of bone fragility, repeated fractures, growth, and bone shape over time. They also check for features that can occur with osteogenesis imperfecta type 18, such as short stature or other skeletal differences. These findings help guide the diagnosis of osteogenesis imperfecta type 18.
A detailed family and health history can help show whether similar bone problems, fractures, or pregnancy losses have happened in relatives. Even when there is no known family history, this step can still be useful because new genetic changes can occur.
X-rays and other imaging studies look for fractures, reduced bone density, bowed bones, or other changes in the skeleton. In babies before birth, ultrasound may sometimes raise concern if bones appear short, fragile, or fractured.
A blood sample is usually used for genetic tests to look for a disease-causing change in the gene linked to this subtype. This is the main way to confirm the genetic diagnosis of osteogenesis imperfecta type 18 and to separate it from other forms of brittle bone disease.
How is Osteogenesis imperfecta type 18 diagnosed?
Doctors usually diagnose osteogenesis imperfecta type 18 by putting together the history of bones that break easily, a physical exam, and imaging tests such as X-rays that can show fragile, bent, or healing bones; in a severe case, it may first be suspected during pregnancy on an ultrasound. A bone density scan and family history can also help, and genetic testing can confirm the exact type by finding the gene change linked to type 18.
Stages of Osteogenesis imperfecta type 18
Osteogenesis imperfecta type 18 does not have defined progression stages. This is because it is a genetic condition identified by its pattern of features, rather than an illness that moves through clear step-by-step phases over time. Doctors usually start with a conversation about symptoms such as frequent fractures, bone deformities, growth problems, and sometimes breathing or mobility difficulties, including the early symptoms of osteogenesis imperfecta type 18 seen in infancy or early childhood. Diagnosis is usually confirmed with a physical exam, imaging such as X-rays, and genetic testing, while follow-up focuses on bone health, growth, movement, and any complications that may develop.
Outlook and prognosis
The outlook for osteogenesis imperfecta type 18 varies widely, but it is often serious because marked bone fragility can begin before birth or in early infancy and may be accompanied by growth problems, chest wall deformity, and progressive skeletal complications. In the most severely affected infants, the prognosis can be poor, with an increased risk of early death from respiratory insufficiency and complications related to multiple fractures and an underdeveloped thorax. Children who survive infancy may still face recurrent fractures, chronic pain, short stature, scoliosis, reduced mobility, and hearing or dental problems, so long-term orthopedic, pulmonary, and rehabilitation care is usually needed. Because this is a very rare subtype, published data on life expectancy are limited, and prognosis is often estimated from the individual pattern of bone disease and breathing function rather than from large studies. With modern supportive treatment, including fracture prevention, respiratory monitoring, physical therapy, and timely surgery when needed, some affected individuals can achieve improved comfort and function. Overall, mortality is highest in the most severe neonatal presentations, while outcomes are more favorable in those with less severe skeletal and respiratory involvement.
Long-term effects
For many living with osteogenesis imperfecta type 18, the long-term picture is shaped mainly by very fragile bones, growth problems, and limits on movement. Long-term effects vary widely, but this type is usually associated with severe skeletal involvement from early life. Some children have major medical needs in infancy, while those who survive longer may continue to have fractures, bone deformity, and ongoing physical disability into later childhood and adulthood. Doctors may track these changes over years to see how osteogenesis imperfecta type 18 is affecting growth, breathing, and daily function.
Bones can break easily over time, sometimes with routine handling or minor bumps. Repeated fractures may lead to pain, time in casts or splints, and slower physical development.
Ongoing fragility can cause long bones to bow and the chest, spine, or limbs to develop an altered shape. For many, this can mean increasing skeletal changes as they grow.
Growth is often markedly reduced in osteogenesis imperfecta type 18, and children may remain much smaller than expected for age. Limited bone growth and repeated fractures both contribute to this long-term effect.
Many living with osteogenesis imperfecta type 18 have delayed motor milestones and need help with sitting, standing, or walking. Over time, daily routines may depend more on supportive equipment because weak bones and deformities make movement harder.
How is it to live with Osteogenesis imperfecta type 18?
Living with osteogenesis imperfecta type 18 often means living with very fragile bones from early life, and for many this can bring frequent fractures, bone deformities, pain, short stature, and sometimes breathing or feeding difficulties. Daily life may need careful handling, extra planning for movement and play, mobility aids, physical therapy, and regular medical visits, because even small bumps or routine activities can lead to injury. For parents, siblings, and other caregivers, the condition can shape the whole household through constant attention to safety, appointments, and emotional stress, yet many living with osteogenesis imperfecta and their families build steady routines, adapt the home, and find support that makes day-to-day life safer and more manageable.
Treatment and drugs
Treatment for osteogenesis imperfecta type 18 focuses on protecting fragile bones, easing pain, and supporting growth, movement, and breathing, because there is no cure that fixes the underlying genetic change. Care often involves a team that may include bone specialists, orthopedic surgeons, physical and occupational therapists, and, in babies with more severe disease, experts in breathing and feeding support. Doctors sometimes recommend a combination of lifestyle changes and drugs, such as careful physical therapy, splints or braces, surgery to stabilize bones, and medicines that may help strengthen bone in some children, although response can vary. Many living with osteogenesis imperfecta type 18 also need prompt treatment for fractures and close follow-up for spine shape, hearing, teeth, and mobility, since these can affect day-to-day life. Not every treatment works the same way for every person, so care is usually tailored to age, symptom severity, and the early symptoms of osteogenesis imperfecta type 18.
Can you cure Osteogenesis imperfecta type 18?
No, osteogenesis imperfecta type 18, a rare form of brittle bone disease, cannot currently be cured. Treatment focuses on support and day-to-day care, such as helping prevent broken bones, managing pain, improving movement with physical therapy, and treating problems with growth, breathing, or other body systems that can happen in more severe forms.
Non-drug treatment
Daily care for osteogenesis imperfecta type 18 usually centers on protecting fragile bones, building safe movement, and supporting breathing, feeding, and development. Many living with osteogenesis imperfecta type 18 need care from several specialists because needs can change with age and with how severe the condition is. Managing this condition often means combining rehabilitation, equipment, and sometimes surgery so everyday tasks like sitting, feeding, and moving can become safer and more comfortable.
Physical therapy helps improve strength, positioning, balance, and gentle movement while lowering the chance of injury. For many, this can mean practicing safe transfers, supported sitting, or water-based exercise with close guidance.
Occupational therapy focuses on daily activities such as dressing, bathing, feeding, writing, and using the hands safely. Splints, adapted utensils, and small changes at home or school can make routine tasks easier.
Caregivers are often taught how to lift, carry, diaper, and reposition a child with less stress on the bones and joints. This can be especially important when early symptoms of osteogenesis imperfecta type 18 include frequent fractures or marked bone fragility.
Braces, seating supports, standing frames, walkers, and wheelchairs can improve comfort and mobility. The right equipment also helps with posture and can make school, play, and travel safer.
Your genes may have an impact on how drugs work for you
For people living with osteogenesis imperfecta type 18, small differences in their genes can shape how well certain medicines help with bone strength, pain, or muscle-related symptoms, so one person may improve more than another even when they take similar treatment. In day-to-day life, this can mean one child has fewer breaks or less pain after treatment, while another still needs closer follow-up and changes to the plan. At this point, using gene testing to choose medicines is not a routine part of care for this type, but the exact genetic cause can still give doctors helpful clues about which treatments may be more or less useful.
Pharmacological treatments
Living with osteogenesis imperfecta type 18 often means dealing with fragile bones, frequent fractures, and ongoing pain, so medicines are mainly used to support bone health and comfort rather than cure the condition. There is no drug proven to treat the genetic cause of osteogenesis imperfecta type 18 itself, but some medicines used for other forms of osteogenesis imperfecta may still be considered. Treatment is individualized, especially in children, and usually sits alongside physical therapy, nutrition, and fracture care. Finding the right medication can be a process of trial, patience, and adjustment.
Drugs such as pamidronate, zoledronic acid, and alendronate are the main medicines most often used to strengthen bone in osteogenesis imperfecta. They can help increase bone density and may lower fracture rates in some children, although benefit can vary and evidence for osteogenesis imperfecta type 18 specifically is limited.
Acetaminophen and nonsteroidal anti-inflammatory drugs such as ibuprofen are commonly used to ease pain from fractures, procedures, or day-to-day bone pain. Stronger pain medicines may be used for a short time after a major fracture or surgery, with close medical supervision.
Calcium and vitamin D may be recommended if intake is low or blood levels are below target, because healthy bone needs both to mineralize properly. These supplements do not fix the underlying gene change, but they can support overall bone care and are sometimes reviewed when early symptoms of osteogenesis imperfecta type 18 appear.
Some people with osteogenesis imperfecta type 18 may receive antibiotics around the time of surgery to prevent infection, along with standard medicines for anesthesia and pain control. These drugs treat complications or procedures, not the bone fragility itself.
Genetic influences
Simple falls or routine play can lead to broken bones in osteogenesis imperfecta type 18, and that happens because this condition is caused by inherited changes in a gene called TENT5A. Osteogenesis imperfecta type 18 follows an autosomal recessive inheritance pattern, which means a child must inherit two nonworking copies of the gene, one from each parent. Parents are often carriers, meaning they hold one gene change and may not show symptoms. The genetic cause of osteogenesis imperfecta type 18 affects how bone-forming cells build and harden bone, so many living with this type have very fragile bones and may also have short stature or delays in motor milestones. Because this is a clearly inherited form of OI, genetic counseling can help families understand the chance of it happening again and whether testing may be useful for relatives.
Is Osteogenesis imperfecta type 18 genetic?
Genetics are central to osteogenesis imperfecta type 18. It is caused by harmful changes in the PLS3 gene, and different genetic variations can affect how severe symptoms are, even within the same family.
Having a genetic risk is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, having a variant associated with a condition points to a possible association rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, one well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
When families are trying to understand the best treatment for osteogenesis imperfecta type 18, the exact genetic cause can make a real difference. Genetic testing helps confirm this rare subtype and can separate it from other brittle-bone conditions that may need a different approach. In osteogenesis imperfecta type 18, genetics usually guide the overall care plan more than they change how your body processes common medicines. Genetics is only one factor, but knowing the subtype can help doctors decide whether to use bone-strengthening medicines such as bisphosphonates, how closely to monitor growth and spine problems, and what other health issues to watch for. For many living with osteogenesis imperfecta type 18, treatment still focuses on fracture care, physical therapy, surgery when needed, and supportive care, because no approved medicine can yet correct the underlying gene change.
Interactions with other conditions
People living with osteogenesis imperfecta type 18 often deal with more than fragile bones, because the chest wall and spine can also be affected, which may make breathing problems more likely. This means common illnesses such as colds, flu, or pneumonia can hit harder and may lead to more serious shortness of breath than they would in someone without osteogenesis imperfecta type 18. Doctors call it a “comorbidity” when two conditions occur together. In some children, feeding difficulties, poor growth, or muscle weakness can add to the strain on the lungs and make recovery from other illnesses slower. Osteogenesis imperfecta type 18 can also overlap with spinal curvature and reduced mobility, which may increase the risk of pain, constipation, and pressure-related skin problems over time. Because this type is rare and often severe, care is usually safest when bone specialists, lung specialists, rehabilitation teams, and primary care clinicians work together.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Osteogenesis imperfecta type 18?
Other forms of brittle bone disease, including other types of osteogenesis imperfecta, are the main conditions doctors may confuse with osteogenesis imperfecta type 18 because they can also cause very weak bones, repeated fractures, and poor growth. They may also look at other rare problems that stop bones from hardening normally, such as hypophosphatasia or severe rickets, and some inherited conditions that cause both fragile bones and stiff joints. In babies and young children, doctors may also need to rule out fractures from other causes, including injury, because the early signs can sometimes overlap.
History
Long before there were scans, lab tests, or modern genetics, doctors and families had noticed that some children had bones that broke far more easily than expected. What could look like repeated injuries after a small fall, being lifted, or even during normal handling was gradually recognized as part of a medical condition rather than simple bad luck. Over time, these observations helped shape what we now know as osteogenesis imperfecta, a group of conditions that affect bone strength.
Early descriptions of brittle bone disease focused mostly on what people could see: frequent fractures, short stature, bowed limbs, and in some cases problems with growth or breathing. Because older medical records were limited, the more severe forms were often described only by symptoms, and many different types were not clearly separated from one another. Not every early description was complete, yet together they helped doctors realize that osteogenesis imperfecta could vary a lot from one person to the next.
As medical science evolved, imaging, newborn care, and later genetic research made it possible to sort osteogenesis imperfecta into more specific types. This led to the recognition of newer subtypes, including osteogenesis imperfecta type 18, which was identified as a distinct form within the broader condition. People living with osteogenesis imperfecta type 18 often come to medical attention very early in life because the bone changes can be severe, and doctors may also look for problems involving growth, the chest, and breathing.
The history of osteogenesis imperfecta type 18 also reflects a larger shift in medicine: moving from describing what the body looks like on the outside to understanding the biological changes underneath. That has improved diagnosis and helped families get clearer answers after the early symptoms of osteogenesis imperfecta type 18 appear. It has also reduced some past misunderstandings, since repeated fractures in a fragile-bone condition can sometimes be mistaken for injury from another cause. Today, the condition is still considered rare, but the picture is much clearer than it once was, and care is better informed by both long-term observation and modern research.